PL3770162T3 - Pochodne dihydrochromenu - Google Patents

Pochodne dihydrochromenu

Info

Publication number
PL3770162T3
PL3770162T3 PL19770755.7T PL19770755T PL3770162T3 PL 3770162 T3 PL3770162 T3 PL 3770162T3 PL 19770755 T PL19770755 T PL 19770755T PL 3770162 T3 PL3770162 T3 PL 3770162T3
Authority
PL
Poland
Prior art keywords
dihydrochromene
derivatives
dihydrochromene derivatives
Prior art date
Application number
PL19770755.7T
Other languages
English (en)
Inventor
Hitoshi Ban
Seiji Kamioka
Yusuke SAWAYAMA
Miki HASHIZUME
Original Assignee
Sumitomo Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma Co., Ltd. filed Critical Sumitomo Pharma Co., Ltd.
Publication of PL3770162T3 publication Critical patent/PL3770162T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PL19770755.7T 2018-03-20 2019-03-19 Pochodne dihydrochromenu PL3770162T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018052971 2018-03-20
PCT/JP2019/011439 WO2019181939A1 (ja) 2018-03-20 2019-03-19 ジヒドロクロメン誘導体

Publications (1)

Publication Number Publication Date
PL3770162T3 true PL3770162T3 (pl) 2023-06-05

Family

ID=67986459

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19770755.7T PL3770162T3 (pl) 2018-03-20 2019-03-19 Pochodne dihydrochromenu

Country Status (22)

Country Link
US (3) US10807993B2 (pl)
EP (1) EP3770162B1 (pl)
JP (4) JP6733072B2 (pl)
KR (1) KR102799186B1 (pl)
CN (1) CN111886237B (pl)
AU (1) AU2019239481B2 (pl)
BR (1) BR112020017481A8 (pl)
CA (1) CA3092255A1 (pl)
CY (1) CY1126034T1 (pl)
DK (1) DK3770162T3 (pl)
EA (1) EA202092206A1 (pl)
ES (1) ES2941771T3 (pl)
FI (1) FI3770162T3 (pl)
HU (1) HUE062256T2 (pl)
MX (1) MX2020009763A (pl)
MY (1) MY202583A (pl)
PH (1) PH12020551497A1 (pl)
PL (1) PL3770162T3 (pl)
PT (1) PT3770162T (pl)
SG (1) SG11202007979UA (pl)
TW (1) TWI899051B (pl)
WO (1) WO2019181939A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111886237B (zh) * 2018-03-20 2025-02-07 住友制药株式会社 二氢色烯衍生物
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
WO2025100519A1 (ja) * 2023-11-09 2025-05-15 住友ファーマ株式会社 ジヒドロクロメン誘導体を含むがんの治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045707A1 (en) 1999-12-21 2001-06-28 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US20090111805A1 (en) 2005-02-24 2009-04-30 Pfizer Inc. Bicyclic heteroaromatic derivatives useful as anticancer agents
EP1996550A2 (en) * 2005-09-27 2008-12-03 Novartis AG Carboxyamine compounds and their use in the treatment of hdac dependent diseases
EP1847542A1 (en) 2006-04-21 2007-10-24 Laboratorios del Dr. Esteve S.A. Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
EP3067054B1 (en) * 2007-09-10 2020-12-30 Boston Biomedical, Inc. Novel compositions and methods for cancer treatment
KR20180028456A (ko) * 2015-06-22 2018-03-16 다이닛본 스미토모 세이야꾸 가부시끼가이샤 1,4-디치환 이미다졸 유도체
JPWO2016208592A1 (ja) * 2015-06-22 2018-04-05 大日本住友製薬株式会社 二環性複素環アミド誘導体
US10898469B2 (en) * 2016-02-26 2021-01-26 Sumitomo Dainippon Pharma Co., Ltd. Imidazolylamide derivative
TW201821105A (zh) * 2016-10-20 2018-06-16 美商弗瑪治療公司 使用ｈｄａｃ１１抑制劑之方法
CN111886237B (zh) * 2018-03-20 2025-02-07 住友制药株式会社 二氢色烯衍生物
JP2020019752A (ja) 2018-08-03 2020-02-06 大日本住友製薬株式会社 クロマン誘導体

Also Published As

Publication number Publication date
MY202583A (en) 2024-05-09
DK3770162T3 (da) 2023-04-24
EP3770162B1 (en) 2023-03-15
CN111886237B (zh) 2025-02-07
SG11202007979UA (en) 2020-09-29
CN111886237A (zh) 2020-11-03
JP7247144B2 (ja) 2023-03-28
JP7508620B2 (ja) 2024-07-01
JPWO2019181939A1 (ja) 2020-06-18
KR102799186B1 (ko) 2025-04-23
TW201941774A (zh) 2019-11-01
AU2019239481B2 (en) 2022-11-24
PT3770162T (pt) 2023-03-23
US11639357B2 (en) 2023-05-02
MX2020009763A (es) 2020-10-08
CY1126034T1 (el) 2023-11-15
EP3770162A1 (en) 2021-01-27
US10807993B2 (en) 2020-10-20
US20210002290A1 (en) 2021-01-07
BR112020017481A2 (pt) 2020-12-22
TWI899051B (zh) 2025-10-01
US12398149B2 (en) 2025-08-26
JP2023075288A (ja) 2023-05-30
FI3770162T3 (fi) 2023-06-02
JP6733072B2 (ja) 2020-07-29
ES2941771T3 (es) 2023-05-25
EA202092206A1 (ru) 2020-12-15
PH12020551497A1 (en) 2021-09-01
WO2019181939A1 (ja) 2019-09-26
KR20200135401A (ko) 2020-12-02
US20230219970A1 (en) 2023-07-13
CA3092255A1 (en) 2019-09-26
HUE062256T2 (hu) 2023-10-28
JP2020180140A (ja) 2020-11-05
US20200216461A1 (en) 2020-07-09
BR112020017481A8 (pt) 2022-12-06
NZ767234A (en) 2025-06-27
JP2024123117A (ja) 2024-09-10
AU2019239481A1 (en) 2020-09-10
EP3770162A4 (en) 2021-12-01

Similar Documents

Publication Publication Date Title
DK3467457T3 (en) Vibrationssensor
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
CA185383S (en) Casque
CA185384S (en) Casque
CA185382S (en) Casque
IL271607B1 (en) New azaquinoline histories
CA185385S (en) Casque
IL289197B2 (en) History of 2–hydroxycycloalkane–1–carbamoyl
IL283990A (en) Modified oxopyridine derivatives
DK3554057T3 (en) Audioheadsetsystem
IL293968B2 (en) History of furoindazole
CA184992S (en) Uroflowmeter
IL290815A (en) History of alpha-d-galactopyranoside
CA184991S (en) Uroflowmeter
SG11202012594RA (en) Spirochromane derivatives
LT3796975T (lt) Sulfonilaminobenzamido dariniai
HUE062256T2 (hu) Dihidrokromén-származékok
DK3578923T3 (en) Navigationssystem
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
SG11202006837XA (en) Dihydroindolizinone derivative
ZA202200181B (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
GB201806948D0 (en) Derivatives
CA187782S (en) Pompon-maker
DK3542617T3 (en) Etikette
AU201817245S (en) MC-Roller